Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia
2020-07-04
عنوان الدراسة
Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia
داعم الدراسة
Boehringer Ingelheim
دواء الدراسة
Jardiance
رقم بروتوكول الدراسة
1245/149
حالة الدراسة
Ongoing
موقع الدراسة
Armed Force Hospital (Al-Hada), King Fahad Medical City (Riyadh)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。